Publications (since 2000)

Originals

  • Starlinger, P., Brugger, P., Reiter, C., Schauer, D., Sommerfeldt, S., Tamandl, D., Kuehrer, I., Schoppmann, S. F., Gnant, M. and Brostjan, C., Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Neoplasia 2011. in press.
  • Starlinger, P., Brugger, P., Schauer, D., Sommerfeldt, S., Tamandl, D., Kuehrer, I., Schoppmann, S. F., Gnant, M. and Brostjan, C., Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. Neoplasia 2011. 13: 419-427.
  • Starlinger, P., Alidzanovic, L., Schauer, D., Brugger, P., Sommerfeldt, S., Kuehrer, I., Schoppmann, S. F., Gnant, M. and Brostjan, C., Platelet-stored angiogenesis factors: Clinical monitoring is prone to artifacts. Dis Markers 2011. 31: 55-65.
  • Moll, H. P., Maier, T., Zommer, A., Lavoie, T. and Brostjan, C., The differential activity of interferon-alpha subtypes is consistent among distinct target genes and cell types. Cytokine 2011. 53: 52-59.
  • Moll, H. P., Freudenthaler, H., Zommer, A., Buchberger, E., Lin, X. H., Crisafulli, S., Pandya, Y., Pestka, S., Lavoie, T. and Brostjan, C., Contamination with recombinant IFN accounts for the unexpected stimulatory properties of commonly used IFN-blocking antibodies. Eur J Immunol 2011. 41: 252-254.
  • Assinger, A., Buchberger, E., Laky, M., Esfandeyari, A., Brostjan, C. and Volf, I., Periodontopathogens induce soluble P-selectin release by endothelial cells and platelets. Thromb Res 2011. 127: e20-26.
  • Starlinger, P., Moll, H. P., Assinger, A., Nemeth, C., Hoetzenecker, K., Gruenberger, B., Gruenberger, T., Kuehrer, I., Schoppmann, S. F., Gnant, M. and Brostjan, C., Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. J Thromb Haemost 2010. 8: 1809-1819.
  • Bilalic, S., Veitinger, M., Ahrer, K. H., Gruber, V., Zellner, M., Brostjan, C., Bartel, G., Cejka, D., Reichel, C., Jordan, V., Burghuber, C., Muhlbacher, F., Bohmig, G. A. and Oehler, R., Identification of Non-HLA antigens targeted by alloreactive antibodies in patients undergoing chronic hemodialysis. J Proteome Res 2010. 9: 1041-1049.
  • Bachleitner-Hofmann, T., Friedl, J., Hassler, M., Hayden, H., Dubsky, P., Sachet, M., Rieder, E., Pfragner, R., Brostjan, C., Riss, S., Niederle, B., Gnant, M. and Stift, A., Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma. Oncol Rep 2009. 21: 1585-1592.
  • Moll, H. P., Freudenthaler, H., Zommer, A., Buchberger, E. and Brostjan, C., Neutralizing type I IFN antibodies trigger an IFN-like response in endothelial cells. J Immunol 2008. 180: 5250-5256.
  • Brunner, M., Thurnher, D., Heiduschka, G., Grasl, M., Brostjan, C. and Erovic, B. M., Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients. J Surg Oncol 2008. 98: 545-550.
  • Brostjan, C., Gebhardt, K., Gruenberger, B., Steinrueck, V., Zommer, H., Freudenthaler, H., Roka, S. and Gruenberger, T., Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels. Clin Cancer Res 2008. 14: 2065-2074.
  • Funovics, P., Brostjan, C., Nigisch, A., Fila, A., Grochot, A., Mleczko, K., Was, H., Weigel, G., Dulak, J. and Jozkowicz, A., Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells. Prostaglandins Other Lipid Mediat 2006. 79: 230-244.
  • Gornikiewicz, A., Zommer, A., Jakesz, R., Gnant, M. and Brostjan, C., Retroviral targeting of proliferating endothelial cells. Acta Biochim Pol 2005. 52: 731-735.
  • Stift, A., Sachet, M., Yagubian, R., Bittermann, C., Dubsky, P., Brostjan, C., Pfragner, R., Niederle, B., Jakesz, R., Gnant, M. and Friedl, J., Dendritic cell vaccination in medullary thyroid carcinoma. Clin Cancer Res 2004. 10: 2944-2953.
  • Zellner, M., Gerner, C., Munk Eliasen, M., Wurm, S., Pollheimer, J., Spittler, A., Brostjan, C., Roth, E. and Oehler, R., Glutamine starvation of monocytes inhibits the ubiquitin-proteasome proteolytic pathway. Biochim Biophys Acta 2003. 1638: 138-148.
  • Stift, A., Friedl, J., Dubsky, P., Bachleitner-Hofmann, T., Schueller, G., Zontsich, T., Benkoe, T., Radelbauer, K., Brostjan, C., Jakesz, R. and Gnant, M., Dendritic cell-based vaccination in solid cancer. J Clin Oncol 2003. 21: 135-142.
  • Stift, A., Friedl, J., Dubsky, P., Bachleitner-Hofmann, T., Benkoe, T., Brostjan, C., Jakesz, R. and Gnant, M., In vivo induction of dendritic cell-mediated cytotoxicity against allogeneic pancreatic carcinoma cells. Int J Oncol 2003. 22: 651-656.
  • Brostjan, C., Bayer, A., Zommer, A., Gornikiewicz, A., Roka, S., Benko, T., Yaghubian, R., Jakesz, R., Steger, G., Gnant, M., Friedl, J. and Stift, A., Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy. Cancer 2003. 98: 2291-2301.
  • Brostjan, C., Bellon, T., Sobanov, Y., Lopez-Botet, M. and Hofer, E., Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones. J Immunol Methods 2002. 264: 109-119.
  • Bachleitner-Hofmann, T., Stift, A., Friedl, J., Pfragner, R., Radelbauer, K., Dubsky, P., Schuller, G., Benko, T., Niederle, B., Brostjan, C., Jakesz, R. and Gnant, M., Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells. J Clin Endocrinol Metab 2002. 87: 1098-1104.
  • Hofer, E., Sobanov, Y., Brostjan, C., Lehrach, H. and Duchler, M., The centromeric part of the human natural killer (NK) receptor complex: lectin-like receptor genes expressed in NK, dendritic and endothelial cells. Immunol Rev 2001. 181: 5-19.
  • Gornikiewicz, A., Sautner, T., Brostjan, C., Schmierer, B., Fugger, R., Roth, E., Muhlbacher, F. and Bergmann, M., Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells. FASEB J 2000. 14: 1093-1100.
  • Brostjan, C., Sobanov, Y., Glienke, J., Hayer, S., Lehrach, H., Francis, F. and Hofer, E., The NKG2 natural killer cell receptor family: comparative analysis of promoter sequences. Genes Immun 2000. 1: 504-508.

Reviews

  • Starlinger, P., Gebhardt, K., Gruenberger, T. and Brostjan, C., Systemic effects of anti-VEGF therapy. Eur Surg 2010. 42: 12-16.
  • Brostjan, C., Roka, S., Gornikiewicz, A. and Friedl, J., Antiangiogenese-Ansätze in der Tumortherapie. Acta Chirurgica Austriaca 2000. 32: 251-254.